Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: Are there differences?

Herbert Y. Meltzer

doi:10.1017/S1461145705005183

Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: Are there differences?

Herbert Y. Meltzer^*

^*Corresponding author for this work

Psychiatry and Behavioral Sciences

Research output: Contribution to journal › Review article › peer-review

27 Scopus citations

Original language	English (US)
Pages (from-to)	153-156
Number of pages	4
Journal	International Journal of Neuropsychopharmacology
Volume	8
Issue number	2
DOIs	https://doi.org/10.1017/S1461145705005183
State	Published - Jun 2005

ASJC Scopus subject areas

Pharmacology
Psychiatry and Mental health
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1017/S1461145705005183

Cite this

@article{f7d66741b9304c1b972e318f0622ea54,

title = "Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: Are there differences?",

author = "Meltzer, {Herbert Y.}",

year = "2005",

month = jun,

doi = "10.1017/S1461145705005183",

language = "English (US)",

volume = "8",

pages = "153--156",

journal = "International Journal of Neuropsychopharmacology",

issn = "1461-1457",

publisher = "Cambridge University Press",

number = "2",

}

TY - JOUR

T1 - Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone

T2 - Are there differences?

AU - Meltzer, Herbert Y.

PY - 2005/6

Y1 - 2005/6

UR - http://www.scopus.com/inward/record.url?scp=20044382698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044382698&partnerID=8YFLogxK

U2 - 10.1017/S1461145705005183

DO - 10.1017/S1461145705005183

M3 - Review article

C2 - 15780147

AN - SCOPUS:20044382698

SN - 1461-1457

VL - 8

SP - 153

EP - 156

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

IS - 2

ER -

Focus on the metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: Are there differences?

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this